CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Glaxo Smithkline Consumer Nigeria PLC Company Snapshot
Glaxo Smithkline Consumer Nigeria PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smithkline Consumer Nigeria PLC with three other pharmaceutical manufacturers in Africa: Promopharm SA of Morocco (2017 sales of 511.20 million Moroccan Dirhams [US$54.15 million] ), Fidson Healthcare Limited (14.06 billion Naira [US$45.97 million] ), and Societe Adwya SA which is based in Tunisia (95.34 million Dinar [US$33.75 million] ).

Sales Analysis. During the year ended December of 2017, sales at Glaxo Smithkline Consumer Nigeria PLC were 16.09 billion Naira (US$52.61 million). This is an increase of 11.9% versus 2016, when the company's sales were 14.38 billion Naira. Despite this increase, sales are still well below the level achieved in 2015, when Glaxo Smithkline Consumer Nigeria PLC reported sales of 30.63 billion Naira.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Glaxo Smithkline Consumer Nigeria PLC
  Stock Performance Chart for Glaxo Smithkline Consumer Nigeria PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 14.05
(Figures in Naira)
1 Week 0.0%   13 Weeks -1.7%  
4 Weeks -24.3%   52 Weeks -33.1%  
 
Glaxo Smithkline Consumer Nigeria PLC Key Data:
  Ticker: GLAXOSMITH Country: Nigeria
  Exchanges: NIG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 16,089,728,000
(Year Ending Jan 2018).
Employees: 322
  Currency: Naira Market Cap: 16,802,057,800
  Fiscal Yr Ends: December Shares Outstanding: 1,195,876,000
  Share Type: Closely Held Shares: 555,081,925
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.